Biotech-IgG AB
Industry
- In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Distributors
See more in Biomedtracker
Latest on Biotech-IgG AB
In Vivo
• By Maureen Riordan and Amanda Micklus
Device Transactions Device financing reached $934 million during 2015's first quarter, a slight increase over Q4's $902 million. ( See Exhibit 1. ) Representing 37% of the financing total, follow-on p
Scrip
• By Deanna Kamienski
Financings During the first quarter of 2015, start-up companies raised a total of $2.74 billion, the third quarter in a row in which the record has been broken. (Last quarter’s total was $1.46 billion
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions HalioDx Qiagen NV Qiagen Marseille SA Management of Qiagen NV division Qiagen Marseille SA have formed a new company, HalioDx , through a buy-out